Stock SYNT SYNTHOMER PLC
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Synthomer plc

Equities

SYNT

GB00BNTVWJ75

Market Closed - London S.E.
Other stock markets
 09:05:11 26/04/2024 pm IST 		5-day change 1st Jan Change
235.5 GBX +1.51% Intraday chart for Synthomer plc -1.26% +24.14%
17/04 EARNINGS AND TRADING: Chill Brands shareholder seeks board ejections AN
15/04 Synthomer sells latex compounding operations for EUR27.5 million AN

Summary

  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.43 for the 2023 fiscal year.
  • The company appears to be poorly valued given its net asset value.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For the past twelve months, EPS forecast has been revised upwards.

Weaknesses

  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company has insufficient levels of profitability.
  • The group shows a rather high level of debt in proportion to its EBITDA.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialty Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
SYNTHOMER PLC Stock Synthomer plc
+24.14% 480M
B
ECOLAB INC. Stock Ecolab Inc.
+11.47% 63.22B
A-
SIKA AG Stock Sika AG
-3.47% 46.34B
A-
GIVAUDAN SA Stock Givaudan SA
+13.72% 39.97B
B+
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+17.83% 25.46B
A-
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+7.27% 18.68B
C+
CELANESE CORPORATION Stock Celanese Corporation
-0.57% 17.24B
B+
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.73% 15.81B
A-
SYMRISE AG Stock Symrise AG
+0.22% 14.9B
B+
ALBEMARLE CORPORATION Stock Albemarle Corporation
-19.10% 13.74B
C+
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. SYNT Stock
  4. Ratings Synthomer plc